Sign Up to like & get
recommendations!
2
Published in 2022 at "Cell reports"
DOI: 10.1016/j.celrep.2022.110436
Abstract: HIV-1 clade C envelope immunogens that elicit both neutralizing and non-neutralizing V1V2-scaffold-specific antibodies (protective correlates from RV144 human trial) are urgently needed due to the prevalence of this clade in the most impacted regions worldwide.…
read more here.
Keywords:
scaffold antibodies;
clade;
autologous neutralizing;
v1v2 scaffold ... See more keywords